-
Loading metrics
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
- Geert Leroux-Roels,
- Cathy Maes,
- Frédéric Clement,
- Frank van Engelenburg,
- Marieke van den Dobbelsteen,
- Michael Adler,
- Mario Amacker,
- Lucia Lopalco,
- Morgane Bomsel,
- Anick Chalifour
x
- Published: February 20, 2013
- https://doi.org/10.1371/journal.pone.0055438